Neurocrine Biosciences
Christopher Wallick is a seasoned professional in Health Economics and Outcomes Research (HEOR) with extensive experience across various therapeutic areas, particularly epilepsy and Alzheimer's disease. Currently serving as Senior Director - Global HEOR at Neurocrine Biosciences since May 2023, Christopher has led HEOR initiatives at prominent companies such as Genentech, where responsibilities included developing comprehensive HEOR strategies and generating real-world evidence for key drug launches. Christopher's background also includes roles in oncology, neuroscience, and ophthalmology, alongside academic research in molecular biology. Christopher holds a Master of Science in Pharmaceutical Outcomes Research and a Doctor of Pharmacy, complemented by a Bachelor of Science in Biochemistry from the University of Washington.
This person is not in any teams
This person is not in any offices